Security key
874060205
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK)
CUSIP: 874060205
Q1 2019 13F Holders as of 31 Mar 2019
- Security type / class
- Equity / SPONSORED ADS
- Total 13F shares
- 178,446,454
- Total 13F value
- $3,633,871,563
- Share change
- +114,692,115
- Put/Call ratio
- 104%
- SEC-reported price per share
- $20.37
- Number of holders
- 365
- Value change
- +$2,339,014,740
- Number of buys
- 329
- Number of sells
- 21
Open additional details 1 more signal available
Report period
Q1 2019
Institutions
365
Top holders
10
TAK full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2019
Previous quarter: Q4 2018
TAKEDA PHARMACEUTICAL CO LTD SEC filings
TAKEDA PHARMACEUTICAL CO LTD company facts
TAKEDA PHARMACEUTICAL CO LTD 13D/G history
Broader feeds
Reporting periods
Holder history for CUSIP 874060205
Recent filing periods:
Ownership snapshot
Top reported holders of TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
UBS Group AG
Disclosed value leader
UBS Group AG
Comparable rows
0/15
Latest evidence
31 Dec 2018
13F
Highest disclosed value: $170,699,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
UBS Group AG has the largest disclosed position value at $170.7M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens UBS Group AG's linked filing trail.
Disclosed position value
Top 5
UBS Group AG
$170.7M
BANK OF AMERICA CORP /DE/
$116.03M
CITIGROUP INC
$113.02M
GOLDMAN SACHS GROUP INC
$85.84M
ARROWSTREET CAPITAL, LIMITED PART...
$63.45M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| UBS Group AG |
13F
Company
|
—
class O/S missing
|
$170,699,000
10,148,596 shares
|
— | 31 Dec 2018 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
—
class O/S missing
|
$116,033,000
6,898,473 shares
|
— | 31 Dec 2018 |
| CITIGROUP INC |
13F
Company
|
—
class O/S missing
|
$113,024,000
6,548,306 shares
|
— | 31 Dec 2018 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
—
class O/S missing
|
$85,843,000
5,103,619 shares
|
— | 31 Dec 2018 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
Company
|
—
class O/S missing
|
$63,449,000
3,772,245 shares
|
— | 31 Dec 2018 |
| NORTHERN TRUST CORP |
13F
Company
|
—
class O/S missing
|
$57,440,000
3,414,999 shares
|
— | 31 Dec 2018 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2019
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
365
Shares
178,446,454
Rows available
365
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2019 vs Q4 2018 Across Filers
Q4 2018 holders
82
Q1 2019 holders
365
Holder diff
283
| Investor | Q4 2018 Shares | Q1 2019 Shares | Share Diff | Share Chg % | Q4 2018 value | Q1 2019 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend